Product Information

CALCIUM ACETATE 667 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.4387 per EA under NDC 62135019222. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Feb 5, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Calcium Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CALCIUM ACETATE 667 MG TABLET

Calcium Acetate
$0.4387per EA
High Outlier

Strength

667 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135019222

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

7/22/2026

Active Ingredients

CALCIUM ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202420

FDA Approved

2/5/2013

TE Code

AB

On Market Since

7/1/2019

Pharmacological Classes

Blood Coagulation Factor
Calcium
Cations
Divalent
Increased Coagulation Factor Activity
Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for CALCIUM ACETATE 667 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4387 per EA
All-time high$0.4517 (May 13, 2026)
All-time low$0.3748 (Nov 20, 2024)
52-week high$0.4517
52-week low$0.4134
Median price$0.4008
Average price$0.4073
Largest weekly change-4.6% (Jul 17, 2024)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

-2.2%

6M

+1.2%

1Y

+6.1%

3Y

N/A

5Y

N/A

All

+9.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Calcium Acetate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CALCIUM ACETATE 667 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CALCIUM ACETATE 667 MG TABLET, manufactured by Chartwell RX LLC, is $0.4387 per EA (NDC 62135019222), effective Aug 19, 2026.

How has the price of CALCIUM ACETATE 667 MG TABLET changed over time?

Over the history we have for it, the NADAC for CALCIUM ACETATE 667 MG TABLET has risen 9.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for CALCIUM ACETATE 667 MG TABLET?

Since Apr 17, 2024, the NADAC for CALCIUM ACETATE 667 MG TABLET has ranged from a low of $0.3748 (Nov 20, 2024) to a high of $0.4517 (May 13, 2026), with a median of $0.4008 per EA.

Are there cheaper alternatives to CALCIUM ACETATE 667 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of CALCIUM ACETATE 667 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CALCIUM ACETATE 667 MG TABLET?

CALCIUM ACETATE 667 MG TABLET (NDC 62135019222) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.